Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
18.38
-0.24 (-1.29%)
Apr 30, 2026, 11:54 AM CST
SHE:300653 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 56.78 | 61.99 | 116.84 | 76.58 | 82.49 | 126.49 | Upgrade
|
| Trading Asset Securities | 594.21 | 575.11 | 505.43 | 598.61 | 534.21 | 445.18 | Upgrade
|
| Cash & Short-Term Investments | 650.99 | 637.1 | 622.27 | 675.19 | 616.7 | 571.67 | Upgrade
|
| Cash Growth | -1.51% | 2.38% | -7.84% | 9.48% | 7.88% | 28.52% | Upgrade
|
| Accounts Receivable | 61.15 | 58.59 | 50.77 | 53.6 | 46.85 | 46.8 | Upgrade
|
| Other Receivables | 1.6 | 1.41 | 0.64 | 1.16 | 1.49 | 0.74 | Upgrade
|
| Receivables | 62.74 | 60 | 51.41 | 54.76 | 48.34 | 47.54 | Upgrade
|
| Inventory | 31.53 | 29.55 | 35.18 | 36.72 | 40.69 | 33.98 | Upgrade
|
| Other Current Assets | 4.23 | 6.74 | 3.84 | 3.97 | 4.27 | 10.2 | Upgrade
|
| Total Current Assets | 749.5 | 733.39 | 712.7 | 770.63 | 710.01 | 663.38 | Upgrade
|
| Property, Plant & Equipment | 211.78 | 214.8 | 230.09 | 243.43 | 228.03 | 219.79 | Upgrade
|
| Other Intangible Assets | 29.35 | 29.96 | 32.53 | 35.01 | 37.22 | 38.11 | Upgrade
|
| Long-Term Deferred Tax Assets | 1.16 | 1.17 | 2.33 | 2.78 | 2.67 | 2.24 | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.02 | 0.26 | 0.69 | 0.87 | Upgrade
|
| Other Long-Term Assets | 11.1 | 5.29 | 2.45 | 1.71 | 8.29 | 4.53 | Upgrade
|
| Total Assets | 1,003 | 984.62 | 980.11 | 1,054 | 986.9 | 928.92 | Upgrade
|
| Accounts Payable | 22.29 | 15.87 | 21.82 | 39.11 | 58.88 | 70.01 | Upgrade
|
| Accrued Expenses | 12.17 | 20.58 | 12.27 | 15.9 | 21.92 | 23 | Upgrade
|
| Current Income Taxes Payable | 6.18 | 0.65 | 1.25 | 6.4 | 6.66 | - | Upgrade
|
| Current Unearned Revenue | 10.37 | 11.19 | 13.94 | 12.85 | 6.17 | 22.07 | Upgrade
|
| Other Current Liabilities | 38.01 | 36.96 | 31.51 | 15.75 | 11.98 | 10.96 | Upgrade
|
| Total Current Liabilities | 89.02 | 85.24 | 80.79 | 90 | 105.61 | 126.03 | Upgrade
|
| Long-Term Unearned Revenue | 5.61 | 5.73 | 4.87 | 9.12 | 9.96 | 10.48 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.03 | 4.17 | 5.67 | 6.63 | 6.22 | 7.14 | Upgrade
|
| Total Liabilities | 98.66 | 95.14 | 91.33 | 105.76 | 121.8 | 143.65 | Upgrade
|
| Common Stock | 180 | 180 | 180 | 180 | 180 | 120 | Upgrade
|
| Additional Paid-In Capital | 169.42 | 169.42 | 169.42 | 169.42 | 169.42 | 229.42 | Upgrade
|
| Retained Earnings | 604.73 | 589.98 | 589.29 | 598.65 | 515.69 | 435.85 | Upgrade
|
| Treasury Stock | -49.92 | -49.92 | -49.92 | - | - | - | Upgrade
|
| Shareholders' Equity | 904.23 | 889.48 | 888.78 | 948.07 | 865.11 | 785.27 | Upgrade
|
| Total Liabilities & Equity | 1,003 | 984.62 | 980.11 | 1,054 | 986.9 | 928.92 | Upgrade
|
| Net Cash (Debt) | 650.99 | 637.1 | 622.27 | 675.19 | 616.7 | 571.67 | Upgrade
|
| Net Cash Growth | -1.51% | 2.38% | -7.84% | 9.48% | 7.88% | 28.52% | Upgrade
|
| Net Cash Per Share | 3.60 | 3.56 | 3.47 | 3.75 | 4.26 | 3.19 | Upgrade
|
| Filing Date Shares Outstanding | 177.64 | 177.64 | 177.64 | 180 | 180 | 180 | Upgrade
|
| Total Common Shares Outstanding | 177.64 | 177.64 | 177.64 | 180 | 180 | 180 | Upgrade
|
| Working Capital | 660.48 | 648.15 | 631.91 | 680.63 | 604.39 | 537.35 | Upgrade
|
| Book Value Per Share | 5.09 | 5.01 | 5.00 | 5.27 | 4.81 | 4.36 | Upgrade
|
| Tangible Book Value | 874.88 | 859.52 | 856.25 | 913.05 | 827.89 | 747.16 | Upgrade
|
| Tangible Book Value Per Share | 4.93 | 4.84 | 4.82 | 5.07 | 4.60 | 4.15 | Upgrade
|
| Buildings | - | 196.48 | 194.22 | 192.63 | 161.32 | 156.76 | Upgrade
|
| Machinery | - | 139.64 | 136.66 | 125.6 | 117.8 | 109.13 | Upgrade
|
| Construction In Progress | - | 1.15 | 1.34 | 8.09 | 14.63 | 4.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.